DM Pathophysiology Flashcards

1
Q

Diabetes

A
  • Chronic, metabolic disorder of fat, carb, and protein metabolism
  • Hyperglycemia arising from defects in insulin secretion, action, or both
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type I DM

A
  • B-cell destruction
  • Absolute insulin deficiency
  • 5-10% of DM cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type II DM

A
  • Insulin resistance _ relative insulin deficiency

- 90-95% of all DM cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DM I Pathophysiology

A

Autoimmune cells
destruction of B-cells

Four Features of Disease Progression:

  1. Pre-clinical period: presence of immune markers
  2. Hyperglycemia after 80-90% of B-cells are destroyed due to deficiency of insulin and amylin
  3. Honeymoon phase - transient remission
  4. Established disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T1DM Autoimmune Markers

A
  • Type I diabetes: immune mediated in >95% of cases
  • Idiopathic in less than 5%
  • GAD65 (70-90%), IAA, ICA512, ZnT8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insulin Cleavage

A
  • Synthesized as preproinsulin
  • Cleaved to proinsulin
  • Proinsulin split into insulin and C peptide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T2DM Pathophysiologu

A
  • Progressive, heterogeneous disorder with ongoing B-cell failure
  • Relative insulin deficiency
  • Range from severe insulin resistance, minimal insulin secretory defects, primary defect in insulin secretion
  • Majority of patients have glycemic control that deteriorates with time
  • Metabolic disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T2DM Development

A
  • Healthy individuals: insulin secretion by pancreatic islet allows for normal glucose disposal into insulin-sensitive tissues
  • Prediabetes: genetic predisposition, over-nutrition, and physical inactivity reduce the response to insulin-stimulated glucose uptake that is compensated for by increasing insulin production
  • Type 2 DM: insulin secretion no longer compensates for increased peripheral insulin demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T2DM Progression

A
  • Insulin Resistance
  • Increased insulin production
  • Death/burnout of beta cells
  • Reduced or absent insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T2DM: Insulin Resistance

A
  • Body cells become less responsive to the insulin we make

- Usually takes a long time to develop (years to decades)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T2DM Beta Cell Burnout

A
  • By the time of T2DM diagnosis, more than 80% of B-cells may be gone
  • Progression doesn’t always occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hyperglycemia - Ominous Octet

A
  1. Decreased insulin secretion
  2. Increased glucagon secretion
  3. Increased HGP
  4. Neurotransmitter dysfunction
  5. Decreased glucose uptake
  6. Increased glucose reabsorption
  7. Increased lipolysis
  8. Decreased incretin effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Egregious Eleven: B-Cell destruction Effects

A
  1. Pancreatic B-Cells
  2. Incretin Effect
  3. Alpha-cell defect
    4-6. Adipose, Muscle, Liver
  4. Brain
  5. Colon/Biome
  6. Immune Dysregulation/inflammation
  7. Stomach/Small Intestine
  8. Kidneys: SGLT2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pancreatic B-Cells Dysfunction

A
  • Insulin resistant organs: liver, muscle, adipose tissue (increased lipid exposure can lead to B-cell dysfunction)
  • Other organs: brain, colon, immune system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Incretin Effect

A
  • Resistance to the action of glucose-dependent insulinotrophic polypeptide also called gastric inhibitory polypeptide (GIP)
  • B-cell resistance to the stimulatory effect of GIP on insulin secretion
  • Deficiency of GLP-1: resistance to stimulatory effect of GLP-1 on insulin secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alpha-cell Defect

A

-Increased glucagon

17
Q

Adipose, Muscle Liver

A
  • Insulin promotes fuel storage (anabolism) in these tissues
  • Also prevents the breakdown of release of fuel that have already been stored (catabolism)
  • Insulin resistance and inflammation lead to production/release of FFAs and insulin resistance-provoking proinflammatory cytokines in the adipose cells
18
Q

Brain Effects

A
  • May experience insulin resistance like other organs
  • Increased appetite due to decreased GLP-1/GIP
  • Decreased morning dopamine surge
  • Increased sympathetic tone
19
Q

Colon/Biome

A
  • Gut microbiome role in digestion: strengthens immune system, prevents infection
  • Antibiotic use may increase risk of T2DM: kill “good” bacteria allowing for “bad” bacteria to dominate GI tract, alters nutrient absorption/metabolism
  • Associated insulin resistance
20
Q

Stomach/Small Intestine

A
  • Amylin production decreased as a result of B-cell dysfunction: amylin co-secreted with insulin from B-cell
  • Effects of decreased amylin: accelerated gastric emptying, increased glucose absorption in small intestine, corresponding increases in postprandial glucose levels
21
Q

Kidneys Effects

A
  • As blood glucose increases, the kidney begins to reabsorb the glucose so it will not go into urine
  • Up-regulates SGLT-2 protein in kidney to further hyperglycemia
22
Q

Complexities of Diabetes

A
  • Increased insulin resistance
  • Increased hepatic glucose production
  • B-cell failure or destruction
  • Abnormalities in incretin action
  • Enhanced renal SGLT2 activity
  • Abnormalities of glucagon physiology